In most tumors, Bcl‐2 expression levels are elevated, while Bax expression levels are reduced, which leads to an increase in the amount of Bcl‐2/Bax heterodimers and Bcl‐2 homodimers, thereby inhibiting tumor cell death.30 This evidence concerns the gene BCL2 and neoplasm.